Aventis Pharma Fact Sheet, Aventis Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Fact Sheet    (HOCM)


Tomorrow at 5pm: Get the details of India's #1 defence stock


Here is the latest financial fact sheet of Aventis Pharma. For more details, see the Aventis Pharma quarterly results and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANOFI INDIA Price History

Price Rs 8,355.2
Mkt Cap Rs m 192,419
Vol '000 15.5
P/E X 43.2
P/CF X 39.8
EPS (TTM) Rs 193.5
% ch % -2.4
No. of shares m 23.03
% ch week % -2.1
% ch 1-mth % -0.8
% ch 12-mth % 36.7
52 week H/L Rs 8,999.0/5,900.1
(As on Oct 21, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANOFI INDIA Financials

No. of Mths
Year Ending
12
Dec-14
12
Dec-15
12
Dec-16
12
Dec-17
12
Dec-18
5-Yr Chart
Click to enlarge
SANOFI INDIA EQUITY SHARE DATA
High Rs3,8004,5214,5604,9456,840 
Low Rs2,5003,4454,4003,9014,630 
Sales per share (Unadj.) Rs858.7952.31,028.51,081.81,203.1 
Earnings per share (Unadj.) Rs114.5139.6132.1141.6165.3 
Diluted earnings per shareRs114.5139.6132.1141.6165.3 
Cash flow per share (Unadj.) Rs156.4188.7183.7185.9209.9 
Dividends per share (Unadj.) Rs45.0065.0068.0071.0084.00 
Adj. dividends per shareRs45.0065.0068.0071.0084.00 
Dividend yield (eoy) %1.41.61.51.61.5 
Book value per share (Unadj.) Rs645.2706.5753.6879.9963.6 
Adj. book value per shareRs645.2706.5753.6879.9963.6 
Shares outstanding (eoy) m23.0323.0323.0323.0323.03 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.74.24.44.14.8 
Avg P/E ratio x27.528.533.931.234.7 
P/CF ratio (eoy) x20.121.124.423.827.3 
Price / Book Value ratio x4.95.65.95.06.0 
Dividend payout %39.346.651.550.250.8 
Avg Mkt Cap Rs m72,54591,724103,174101,862132,078 
No. of employees `0003.43.73.63.23.3 
Total wages/salary Rs m2,8823,3333,5533,6854,068 
Avg. sales/employee Rs Th5,735.25,987.06,537.77,691.98,393.8 
Avg. wages/employee Rs Th836.0909.9980.71,137.71,232.4 
Avg. net profit/employee Rs Th764.5877.7839.61,006.51,153.0 
SANOFI INDIA INCOME DATA
Net Sales Rs m19,77521,93023,68624,91427,708 
Other income Rs m643514664807897 
Total revenues Rs m20,41822,44424,35025,72128,605 
Gross profit Rs m3,3894,5915,3515,3726,235 
Depreciation Rs m9661,1301,1881,0221,027 
Interest Rs m5423117 
Profit before tax Rs m3,0613,9704,8045,1466,098 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m666839000 
Tax Rs m1,0901,5941,7621,8862,292 
Profit after tax Rs m2,6363,2153,0423,2603,806 
Gross profit margin %17.120.922.621.622.5 
Effective tax rate %35.640.136.736.637.6 
Net profit margin %13.314.712.813.113.7 
SANOFI INDIA BALANCE SHEET DATA
Current assets Rs m12,62812,43715,75314,43815,922 
Current liabilities Rs m6,5584,9455,0216,0176,235 
Net working cap to sales %30.734.245.333.835.0 
Current ratio x1.92.53.12.42.6 
Inventory Days Days8880766164 
Debtors Days Days2124222921 
Net fixed assets Rs m8,5828,7718,0987,9917,539 
Share capital Rs m230230230230230 
"Free" reserves Rs m14,55916,00417,08820,03421,962 
Net worth Rs m14,85816,27217,35620,26422,192 
Long term debt Rs m00000 
Total assets Rs m22,27624,11425,41227,77729,839 
Interest coverage x638.6993.5209.9468.8872.1 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.90.90.90.9 
Return on assets %11.913.312.111.812.8 
Return on equity %17.719.817.516.117.2 
Return on capital %25.129.627.825.427.5 
Exports to sales %24.224.224.500 
Imports to sales %36.926.128.000 
Exports (fob) Rs m4,7885,3125,80100 
Imports (cif) Rs m7,2985,7206,62700 
Fx inflow Rs m5,4956,6807,1456,3067,587 
Fx outflow Rs m8,0456,5876,8465,2577,145 
Net fx Rs m-2,550932991,049442 
SANOFI INDIA CASH FLOW
From Operations Rs m 2,650 2,132 3,221 4,351 3,739 
From Investments Rs m 613 359 -1,550 -787 -731 
From Financial Activity Rs m -1,217 -1,470 -1,802 -1,884 -1,972 
Net Cashflow Rs m 2,046 1,021 -131 1,680 1,036 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 60.4%
Indian inst/Mut Fund 14.4%
FIIs 14.6%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 15,184
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Aventis House, 54/A, Mathuradas Vasanji Road, Andheri (E), Mumbai-93
E-MAIL k.subramani@sanofi.com WEB www.sanofiindialtd.com
TELEPHONE (022) 2827 8000 FAX (022) 2837 0939
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR S. R. Batliboi & Co.
CHM: Vijay Mallya COMP SEC: K. Subramani YEAR OF INC: 1956 BSE CODE: 500674 FV (Rs): 10 DIV YIELD (%): 1.0

Read: SANOFI INDIA 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   TTK HEALTHCARE  STRIDES PHARMA SCIENCE  LUPIN  WYETH  PROCTER & GAMBLE HEALTH  

Compare SANOFI INDIA With:   TTK HEALTHCARE  STRIDES PHARMA SCIENCE  LUPIN  WYETH  PROCTER & GAMBLE HEALTH  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 163 Points Higher; Metal and Realty Stocks Witness Buying(Closing)

It was indeed a volatile trading day for share markets in India today. After staging a gap-up opening, Indian share markets reversed gains.

Views on news

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - TEVA PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS